FancyFinancy

Info--not advice. Small-Cap, VC, Alt Lending. Impact Investing. Crowd Funding. A media account powered by Content Carnivores.

[FancyFinancy @FancyFinancy]

GeoVax Responds to Detection of Clade I #Mpox in North Carolina Wastewater $GOVX https://t.co/KWANCJ52b4

[FancyFinancy @FancyFinancy]

https://t.co/ZaTbxyHbZv

[FancyFinancy @FancyFinancy]

GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations https://t.co/S87JoalSId $GOVX

[FancyFinancy @FancyFinancy]

HHS Secretary Robert F. Kennedy Jr. told CBS News that single-strain vaccines aren't effective for fast-mutating respiratory viruses. The FDA is now focusing on multi-strain vaccines, benefiting GeoVax's polyvalent COVID-19 vaccine GEO-CM04S1. $GOVX

https://t.co/Gtc0ISd5Jw

[FancyFinancy @FancyFinancy]

Utah is swiftly emerging as a hotspot for life sciences, bolstered by the robust expansion of commercial real estate propelling this vibrant industry. Uncover the reasons behind Utah's allure for innovation and investment! #UtahInnovation #LifeSciences

https://t.co/tFfukJHWEH

[FancyFinancy @FancyFinancy]

$GOVX to Present at the Noble Capital Markets Emerging Growth Equity Conference December 3, 2024. Video webcast available the following day on https://t.co/0PJod6ey0n #mpox #immunocompromised #mva

[FancyFinancy @FancyFinancy]

$GOVX working on addressing the shortage of available #MPOX vaccine. Update from CEO on the disease and the growing need here. https://t.co/IzmYF7XWLX

[FancyFinancy @FancyFinancy]

$GOVX milestones met, including plans for a Phase 2 trial of Gedeptin for first recurrent head and neck cancer in combination with an immune checkpoint inhibitor. Full report here. https://t.co/J7NBZw1fUw

[FancyFinancy @FancyFinancy]

Joshua Hill, MD, who headed the ImmunOptimize scientific committee. “We need a grassroots effort to address the unmet needs of immunocompromised patients. The time is right to bring the conversations to the forefront.” #COVID $GOVX https://t.co/JgrHkYDfV9

[B2i Digital @b2idigital]

We want to welcome @Geovax_News to the @ROTHCapital Partners 3rd Annual Healthcare Opportunities Conference October 9th. See their profile on @B2iDigital at https://t.co/5MsVsQ9rvX

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and therapy for advanced head and neck cancer. Additional development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, and Marburg), malaria and Zika virus, as well as therapies for various solid tumors. (Source: Company Website 08.06.24)

We look forward to seeing the continued results from David A. Dodd, Arban Domi, Mary Hauser, Susan Hensley, MS, RAC, Kelly McKee, Mark Newman, John Niles, Tom O'Brien, Sreenivasa Rao Oruganti, J. Marc Pipas, MD, Erica Raiden, Mark Reynolds, John W. Sharkey, Jeff Welch, Ashley Zuniga, PhD PMP and the entire GeoVax Labs, Inc. team!

Thanks to the stellar team at ROTH for organizing this conference: Sagar Sheth, Byron Roth, Isabel Mattson-Pain, Amanda McAdams, Otilia "Charo" Montano, Benjamin Bowen, James Antonopoulos, Jason Wittes, Jonathan Aschoff, Ph.D., Boobalan Pachaiyappan, Ph.D. and many others

ROTH is a relationship-driven investment bank headquartered in Newport Beach, CA. For more information on ROTH, please visit https://t.co/f7LaejqxRB.

We hope you’ll be able to attend this pivotal event shaping the future of healthcare innovation.

[FancyFinancy @FancyFinancy]

#WHO Q&A on #mpox refreshed with latest information https://t.co/lx8wx6DgVx

[FancyFinancy @FancyFinancy]

https://t.co/XD3zqAFURI

[FancyFinancy @FancyFinancy]

Follow-Through Friday https://t.co/cOr7aGeEQx

[FancyFinancy @FancyFinancy]

#vaccines #COVID19 #immunocompromised #MVA $GOVX Both antibody-and cell-mediated responses should be considered in assessing vaccine immunogenicity. The study also highlights the importance of vaccination in immunocompromised patients. https://t.co/cFkBlS9aFp

[FancyFinancy @FancyFinancy]

GeoVax Commences Site Expansion for Phase 2 Trial of NextGen #Covidvaccines #geovax #manufacturing #MVA #immunocompromised $GOVX https://t.co/ZjUPcSY4On

[FancyFinancy @FancyFinancy]

https://t.co/uRMWT4bQHy

[FancyFinancy @FancyFinancy]

Sharing this headline from $GOVX. Watch the clip from YouTube stock guru Steven Van Metre for his take on it at the 20-minute mark. https://t.co/BuS1JbpQlJ

[FancyFinancy @FancyFinancy]

It's time for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023
https://t.co/SFz0Pfebrw

[FancyFinancy @FancyFinancy]

It's time for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023
https://t.co/SFz0Pfebrw

[FancyFinancy @FancyFinancy]

This conference is for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023
https://t.co/SFz0Pfebrw